Evaluating the impact of 2006 Australasian Clinical Practice Guidelines for nutrition in children with cystic fibrosis in Australia

被引:8
作者
Ruseckaite, Rasa [1 ]
Pekin, Natalie [1 ]
King, Susannah [2 ,3 ]
Carr, Erin [4 ]
Ahern, Susannah [1 ]
Oldroyd, John [1 ]
Earnest, Arul [1 ]
Wainwright, Claire [5 ,6 ]
Armstrong, David [4 ]
机构
[1] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Alfred Hlth, Melbourne, Vic, Australia
[3] La Trobe Univ, Dept Nutr Rehabil & Sport, Melbourne, Vic, Australia
[4] Monash Hlth, Monash Med Ctr, Melbourne, Vic, Australia
[5] Lady Cilento Childrens Hosp, Brisbane, Qld, Australia
[6] Univ Queensland, Brisbane, Qld, Australia
关键词
Cystic fibrosis; Guidelines; Nutrition; Registry; PSEUDOMONAS-AERUGINOSA; GROWTH; OUTCOMES; PREVALENCE; MANAGEMENT; REGISTRIES; INFECTION; CHILDHOOD; MORTALITY; IVACAFTOR;
D O I
10.1016/j.rmed.2018.07.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the association between the implementation of the 2006 Australasian Clinical Practice Guidelines for Nutrition in Cystic Fibrosis (CF) and the nutritional status of children participating in the Australian Cystic Fibrosis Data Registry (ACFDR). Methods: This research consisted of a quantitative study using ACFDR data and a survey of clinicians and dietitians treating children with CF. Two independent cohorts of children (2-5 years and 6-11 years) were selected from ACFDR between 1998 and 2014 (N = 2304). Generalised estimating equation model was used to assess weight, height and body mass index (BMI) z-scores for each patient before and after the implementation of the nutrition guidelines. A nationwide online survey was sent to 48 clinicians to explore the enablers and barriers to implementation of the guidelines. Results: Data analysis showed significant increase (p < 0.05) in mean weight, height and BMI z-scores ranging from 0.06 to 0.18 after implementation of the guidelines in both cohorts of children. Nineteen (39%) clinicians participated in the survey. The majority of the respondents adopted the recommendations into their practice and used the guidelines as part of their professional development. Structural barriers included a lack of adequate staff resources and clinic space for consultations, inappropriate staff classification, high staff turnover and lack of mentoring support. Conclusion: In children participating in the ACFDR, nutritional status improved after the implementation of the 2006 guidelines. Survey results revealed enablers and barriers to guideline implementation and will inform implementation strategies for the revised Australasian nutrition guidelines for CF, released in 2017.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 43 条
  • [1] Ahern S., 2017, 18 MON U DEP EP PREV, P51
  • [2] Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry
    Ahern, Susannah
    Sims, Geoff
    Earnest, Arul
    Bell, Scott C.
    [J]. INTERNAL MEDICINE JOURNAL, 2018, 48 (06) : 721 - 723
  • [3] [Anonymous], 2000, VITAL HLTH STAT
  • [4] Cystic fibrosis in Australia, 2009: results from a data registry
    Bell, Scott C.
    Bye, Peter T. P.
    Cooper, Peter J.
    Martin, A. James
    McKay, Karen O.
    Robinson, Phillip J.
    Ryan, Gerard F.
    Sims, Geoff C.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2011, 195 (07) : 396 - 400
  • [5] Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor
    Borowitz, Drucy
    Lubarsky, Barry
    Wilschanski, Michael
    Munck, Anne
    Gelfond, Daniel
    Bodewes, Frank
    Schwarzenberg, Sarah Jane
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (01) : 198 - 207
  • [6] Validation of the theoretical domains framework for use in behaviour change and implementation research
    Cane, James
    O'Connor, Denise
    Michie, Susan
    [J]. IMPLEMENTATION SCIENCE, 2012, 7
  • [7] Normal growth in cystic fibrosis associated with a specialised centre
    Collins, CE
    MacDonald-Wicks, L
    Rowe, S
    O'Loughlin, EV
    Henry, RL
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (03) : 241 - 246
  • [8] A COMPARISON OF SURVIVAL, GROWTH, AND PULMONARY-FUNCTION IN PATIENTS WITH CYSTIC-FIBROSIS IN BOSTON AND TORONTO
    COREY, M
    MCLAUGHLIN, FJ
    WILLIAMS, M
    LEVISON, H
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (06) : 583 - 591
  • [9] Cystic Fibrosis Australia, 2008, CYST FIBR STAND CAR
  • [10] Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
    Davies, Jane C.
    Wainwright, Claire E.
    Canny, Gerard J.
    Chilvers, Mark A.
    Howenstine, Michelle S.
    Munck, Anne
    Mainz, Jochen G.
    Rodriguez, Sally
    Li, Haihong
    Yen, Karl
    Ordonez, Claudia L.
    Ahrens, Richard
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (11) : 1219 - 1225